8 followers
Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of its lead indication, wet ag... Read more
Laurent Fischer
SpringWorks Therapeutics
6 followers
Freenome
5 followers
Kymera Therapeutics
5 followers
C4 Therapeutics
5 followers
MindMed
5 followers
Summit Therapeutics
5 followers
4D Molecular Therapeutics
4 followers
Valo
3 followers
Rigel Pharmaceuticals
3 followers
PureTech Health
3 followers
Rani Therapeutics
2 followers
Explore companies